Dexcom could be back on track with its earnings despite tariffs, a warning letter, and a disappointing showing in 2024. The San Diego, CA-based company reported 1Q25 revenue of $1.03 billion, beating ...
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. A warning letter posted Tuesday by the Food and Drug ...
DexCom is building increasingly user-friendly devices that continuously monitor blood glucose levels, and a new collaboration between DexCom and Google could lead to the smallest such devices yet.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results